Fasting Insulin
Females, Age 20-29
The median fasting insulin for US females aged 20-29 is 10.9 µU/mL (65 pmol/L), with 90% of the population falling between 3.3 µU/mL and 33.2 µU/mL.
NHANES 2017-March 2020 Pre-Pandemic 2017-2020 · Sample size: 295 participants · Unit: µU/mL
Percentile Distribution
Unit:
| Percentile | P5 | P10 | P25 | P50 | P75 | P90 | P95 |
|---|---|---|---|---|---|---|---|
| Value (µU/mL) | 3.3 | 3.9 | 6.5 | 10.9 | 16.3 | 28 | 33.2 |
| Percentile | Value (µU/mL) |
|---|---|
| P5 | 3.3 |
| P10 | 3.9 |
| P25 | 6.5 |
| P50 | 10.9 |
| P75 | 16.3 |
| P90 | 28 |
| P95 | 33.2 |
3.3 6.5 10.9 16.3 33.2
P5 P25 P50 P75 P95
Data and Methodology
- Dataset
- NHANES 2017-March 2020 Pre-Pandemic ( NHANES 2017-2020 2020 , Survey-weighted percentiles from fasting subsample)
- Survey years
- 2017-2020
- Sample size
- 295 participants
- Reference population
- US civilian non-institutionalized females aged 20-29 from NHANES 2017-March 2020. Includes the full population (not restricted to healthy individuals) to reflect the population distribution.
- Exclusion criteria
-
- Missing fasting insulin measurement (LBXIN)
- Missing or zero fasting sample weight (WTSAF)
- Age outside 20-29 range
- Notes
- Percentiles computed using the combined pre-pandemic fasting-subsample weight (WTSAFPRP). Fasting insulin measured as LBXIN in µU/mL from the fasting subsample.